共 50 条
- [3] Daclizumab phase I/II trial in relapsing-remitting multiple sclerosis: MRI and clinical results MULTIPLE SCLEROSIS, 2006, 12 : S105 - S105
- [5] Magnetic Resonance Imaging Evidence Supporting the Efficacy of Cladribine Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis CNS Drugs, 2024, 38 : 267 - 279
- [7] Self-Organizing Maps as a Tool for Segmentation of Magnetic Resonance Imaging (MRI) of Relapsing-Remitting Multiple Sclerosis 2017 12TH INTERNATIONAL WORKSHOP ON SELF-ORGANIZING MAPS AND LEARNING VECTOR QUANTIZATION, CLUSTERING AND DATA VISUALIZATION (WSOM), 2017, : 43 - 49
- [10] The efficacy of cladribine in patients with relapsing-remitting multiple sclerosis but without the need for ambulatory assistance: magnetic resonance imaging data from a phase II trial MULTIPLE SCLEROSIS, 2008, 14 : S179 - S179